經腸營養市場規模、佔有率和成長分析：按產品類型、給藥方法、階段、應用、分銷管道、最終用戶和地區分類－2026-2033年產業預測

2024 年全球經腸營養市場價值 80 億美元，預計到 2025 年將成長至 85.1 億美元，到 2033 年將成長至 139.8 億美元，在預測期（2026-2033 年）內複合年成長率為 6.4%。

全球經腸營養市場受人口老化和慢性病發病率上升的驅動，這導致對腸內營養解決方案的需求不斷成長。這些透過各種導管輸注的專用液體營養配方，能夠有效減少併發症、縮短住院時間並促進復原。多年來，該市場已從標準配方發展到包括胜肽和免疫調節產品在內的多種選擇。這一顯著成長的背後是醫療保健服務的擴展和有利的報銷政策，這些因素推動了便利產品在臨床環境之外的應用。此外，人工智慧技術的應用透過精準的患者畫像增強了個人化治療，從而實現量身定做的營養解決方案，改善臨床療效並最佳化供應鏈應對力，進而提升了市場活力。

全球經腸營養市場成長要素

慢性病和老齡化相關健康問題的日益普遍，導致需要長期營養支持的患者群體不斷擴大。這一趨勢促使醫療保健專業人員和看護者越來越傾向於選擇經腸營養，其安全性和有效性已被認可。因此，這些產品在醫院、長期照護機構和家庭醫療保健機構的應用日益廣泛。為了滿足不斷成長的需求，製造商正致力於拓展產品線並創新配方。分銷管道的拓展也推動了市場成長，這得益於不同護理機構中臨床應用的增加以及對專業營養解決方案的持續需求。

全球經腸營養市場的限制因素

全球經腸營養市場面臨許多挑戰，包括由於特殊營養補充品價格高昂，醫院、長期照護機構和保險公司對其日益嚴格的審查。預算限制導致這些產品的採用率下降，因為臨床醫生傾向於優先選擇更具成本效益的標準營養補充品和替代營養方案。對這些特殊產品成本效益的不確定性阻礙了其被納入處方集，延遲了採購決策，並最終導致醫療保健提供者不願開立此類處方。這種情況限制了市場滲透率，尤其是在缺乏完善報銷機制的地區，阻礙了整體市場成長，並限制了製造商拓展分銷網路和開展推廣活動的能力。

全球經腸營養市場趨勢

全球經腸營養市場正經歷著向個人化和精準營養的顯著轉變，這主要得益於臨床對個體化營養解決方案日益成長的需求。製造商們正日益專注於開發模組化、可客製化的營養配方，以滿足患者獨特的代謝特徵和治療需求。與臨床醫生和診斷服務機構的合作關係正在興起，共同打造結合宏量營養素和微量營養素的定製配方，並採用高度靈活的劑型和感官特性。這項轉變強調以治療效果為導向的配方和高度靈活的營養支持方案，從而促進患者的耐受性和復原。此外，這也推動了臨床營養各領域的合作研究和創新，代表著患者照護領域的一場變革。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球經腸營養市場規模：依產品類型分類

• 標準（聚合物基）配方
• 基於胜肽的
• 疾病特異性配方
• 其他

全球經腸營養市場規模：依流量類型分類

• 持續的營養支持
• 間歇性營養補充

全球經腸營養市場規模：依階段分類

• 成人
• 兒童

全球經腸營養市場規模：依應用領域分類

• 消化系統疾病
• 腫瘤學
• 糖尿病
• 神經系統疾病
• 其他

全球經腸營養市場規模：依分銷管道分類

• 醫院藥房
• 零售藥房
• 線上管道

全球經腸營養市場規模：依最終用戶分類

• 醫院
• 長期照護機構
• 居家照護環境
• 其他

全球經腸營養市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• Nestle SA（Nestle Health Science）
• Danone SA（Nutricia）
• Fresenius Kabi AG
• B. Braun Melsungen AG
• Otsuka Holdings Co. Ltd.
• Meiji Holdings Co. Ltd.
• Hormel Foods Corporation
• Reckitt Benckiser Group PLC
• Medtrition Inc.
• Nutritional Medicinals LLC
• Kate Farms Inc.
• Real Food Blends
• Global Health Products Inc.
• Victus Inc.
• Ajinomoto Cambrooke Inc.
• Medline Industries LP
• DermaRite Industries LLC
• Cambrooke Therapeutics
• Functional Formularies

結論與建議

Global Enteral Feeding Formulas Market size was valued at USD 8.0 Billion in 2024 and is poised to grow from USD 8.51 Billion in 2025 to USD 13.98 Billion by 2033, growing at a CAGR of 6.4% during the forecast period (2026-2033).

The global enteral feeding formulas market is being driven by an aging population coupled with an increase in chronic diseases, thereby expanding the need for tube-based nutrition solutions. These specialized liquid diets, administered through various tubes, effectively reduce complications, minimize hospital stays, and promote rehabilitation. Over the years, the market has evolved from standard formulations to a broad spectrum of options, including peptide-based and immune-modulating products. Significant growth is rooted in the expansion of home healthcare services and favorable reimbursement policies, facilitating the adoption of convenient products outside clinical settings. Furthermore, the integration of AI technology enhances personalization through precise patient profiling, enabling tailored nutrition solutions that improve clinical outcomes and streamline supply chain responsiveness, thus fostering market dynamism.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enteral Feeding Formulas market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enteral Feeding Formulas Market Segments Analysis

Global enteral feeding formulas market is segmented by product type, flow type, stage, application, distribution channel, end-user and region. Based on product type, the market is segmented into Standard (Polymeric) Formulas, Peptide-Based, Disease-Specific Formulas and Others. Based on flow type, the market is segmented into Continuous Feeding and Intermittent Feeding. Based on stage, the market is segmented into Adults and Paediatrics. Based on application, the market is segmented into Gastrointestinal Diseases, Oncology, Diabetes, Neurological Disorders and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Channels. Based on end-user, the market is segmented into Hospitals, Long-Term Care Facilities, Home Care Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Enteral Feeding Formulas Market

The rising prevalence of chronic diseases and age-related health issues is creating a larger demographic of patients in need of long-term nutritional support. This trend leads healthcare professionals and caregivers to increasingly favor enteral feeding formulas, recognized for their safety and efficacy. As a result, there is growing adoption of these products in hospitals, long-term care facilities, and home healthcare environments. This heightened demand motivates manufacturers to expand their product offerings and innovate their formulations. It also encourages the growth of distribution channels, reinforcing market expansion through enhanced clinical usage and ongoing demand for specialized nutritional solutions across diverse caregiving settings.

Restraints in the Global Enteral Feeding Formulas Market

The Global Enteral Feeding Formulas market faces significant challenges due to the premium pricing of specialized formulas, which leads to heightened scrutiny from hospitals, long-term care facilities, and payers. Budgetary constraints often result in reduced adoption of these products, as clinicians tend to prioritize standard feeds or alternative nutrition strategies that are more cost-effective. The uncertainty surrounding the perceived cost benefits of these specialized products inhibits their inclusion in formularies and slows down purchasing decisions, ultimately discouraging providers from prescribing them. This situation limits market penetration, particularly in areas lacking comprehensive reimbursement, restricting overall market growth and hindering manufacturers' capacity to expand distribution and outreach efforts.

Market Trends of the Global Enteral Feeding Formulas Market

The Global Enteral Feeding Formulas market is witnessing a significant trend towards personalized and precision nutrition, driven by the rising clinical demand for individualized feeding solutions. Manufacturers are increasingly focused on developing modular, customizable formulas that cater to patients' unique metabolic profiles and therapeutic needs. Collaborative partnerships with clinicians and diagnostic services are emerging to create tailored blends of macronutrients and micronutrients, alongside adaptable delivery formats and sensory properties. This shift emphasizes outcome-oriented formulations and adaptable feeding protocols that enhance patient tolerance and recovery. Furthermore, it fosters collaborative research and innovation across the broader clinical nutrition landscape, signaling a transformative movement in patient care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Enteral Feeding Formulas Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Standard (Polymeric) Formulas
• Peptide-Based
• Disease-Specific Formulas
• Others

Global Enteral Feeding Formulas Market Size by Flow Type & CAGR (2026-2033)

• Market Overview
• Continuous Feeding
• Intermittent Feeding

Global Enteral Feeding Formulas Market Size by Stage & CAGR (2026-2033)

• Market Overview
• Adults
• Paediatrics

Global Enteral Feeding Formulas Market Size by Application & CAGR (2026-2033)

• Market Overview
• Gastrointestinal Diseases
• Oncology
• Diabetes
• Neurological Disorders
• Others

Global Enteral Feeding Formulas Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Channels

Global Enteral Feeding Formulas Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Long-Term Care Facilities
• Home Care Settings
• Others

Global Enteral Feeding Formulas Market Size & CAGR (2026-2033)

• North America (Product Type, Flow Type, Stage, Application, Distribution Channel, End-User)
  • US
  • Canada
• Europe (Product Type, Flow Type, Stage, Application, Distribution Channel, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Flow Type, Stage, Application, Distribution Channel, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Flow Type, Stage, Application, Distribution Channel, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Flow Type, Stage, Application, Distribution Channel, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle S.A. (Nestle Health Science)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danone S.A. (Nutricia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meiji Holdings Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hormel Foods Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtrition Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutritional Medicinals LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kate Farms Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Real Food Blends
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Health Products Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Victus Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ajinomoto Cambrooke Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries LP
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DermaRite Industries LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrooke Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Functional Formularies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations